A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers by Stéphanie L. Gaillard, Gloria Broadwater, Andrew Berchuck, William S. Andrews, Laura J. Havrilesky, Brittany A. Davidson, Rebecca A. Previs, Mark D. Starr, John S. Yi, Andrew B. Nixon, Jadee L. Neff, Jose Ramon Conejo-Garcia, Angeles Alvarez Secord

Get full text